We Believe

People with diabetes long for a glucose monitor that is accurate, continuous, non-invasive, and non-intrusive. Our goals focus on improving health, quality of life, and reducing risks of long-term diabetes-related complications by minimizing glucose variability.

Our optical technology provides continuous glucose monitoring that we believe can help people with diabetes achieve better glycemic control without the complexity, inconvenience, and pain of current invasive methods.

Read “In Pursuit of an Ideal”, European Endocrinology 2/2012

Benefits of the C8 MediSensors Optical Glucose Monitor

Review the C8 MediSensors Monitor's benefits and bring your patients the power of light.

Real-Time and Retrospective Data

The C8 MediSensors monitor delivers glucose measurements as frequently as every five minutes to provide a running display of glucose dynamics in real time. It can also store four months of data for a retrospective view of glucose levels over longer periods of time.

Notifications

Users can set custom notifications to alert them to high or low glucose values. Notifications will always vibrate and the user can set audible alerts if desired.

No Constant Recalibration

The C8 MediSensors monitor does not require constant recalibration to maintain sensor accuracy. Except for periodic baseline reference measurements, there is no need for ongoing finger sticks to constantly recalibrate the C8 MediSensors monitor. After being removed and put back on, the monitor will resume measuring glucose – no recalibration or sensor replacement required.

Specificity

The Raman spectrum for the glucose molecule has a highly unique signature, so it can be discriminated from the spectra of other compounds in the body. Through proprietary and sophisticated regression analysis techniques, the C8 MediSensors monitor detects the Raman signature of glucose and determines a glucose measurement with a high degree of specificity.

The Power of Light: Using Raman Spectroscopy to Measure Glucose

Our technique involves shining a monochromatic light source into the skin and detecting the scattered light. The colors generated by Raman scattering are very specific to the exact chemical structure of the molecules in the sample. The molecules' various shapes, sizes, atoms, and types of chemical bonds will generate unique Raman spectra, a unique Raman "fingerprint" that can be used to non-invasively read and measure glucose.

A Simple Explanation of
Raman Spectroscopy

Advisors

Barry H. Ginsberg, M.D., Ph.D.

Medical Advisor

Dr. Ginsberg is the Chief Executive Officer of Diabetes Technology Consultants. Until 2007, he was Vice President for Worldwide Medical Affairs for the Diabetes Division of BD Medical Systems, where he led the medical aspects of the diabetes program for 17 years. Dr. Ginsberg is an internationally recognized expert in diabetes, blood glucose monitoring and implantable sensors. He is on the Board of Directors of Biodel, Inc. and D-Medical Industries, LTD, is consulting medical director for Agamatrix, Inc. and Facet Technologies, LLC, is a senior consultant to the Artificial Pancreas Project of the JDRF, and a diabetes consultant to the Helmsley Foundation and to GE HealthCare. Dr. Ginsberg joined BD from the University of Iowa, where he was professor of internal medicine and biochemistry. He was a Principal Investigator of the Diabetes Control and Complications Trial. Dr. Ginsberg has an M.D. and Ph.D. degree in Molecular Biology from Albert Einstein College of Medicine and trained in internal medicine at Beth Israel Hospital (Boston) and at the Diabetes Branch of the National Institutes of Health. He is Board Certified in Internal Medicine and Endocrinology.

Technical Advisor

Professor Mathies is Dean of the College of Chemistry, and Gilbert Newton Lewis Professor of Chemistry at the University of California, Berkeley. Professor Mathies leads two research groups that are based on modern optical laser spectroscopic techniques. The "Raman Group" uses resonance Raman spectroscopy, femtosecond time-resolved absorption spectroscopy, and the new technique called Femtosecond Stimulated Raman Spectroscopy (FSRS) to study chemical and biological reaction dynamics with a focus on the mechanism of photoactive proteins that mediate information and energy transduction. The "DNA/Microchip Group" exploits the sensitivity of laser excited fluorescence detection to develop high-performance microfabricated chemical and biochemical analysis methods and "lab-on-a-chip" apparatus. Prof. Mathies holds Ph.D. and M.S. degrees from Cornell University and a B.S. from the University of Washington. He was Helen Hay Whitney Fellow at Yale University and Alfred P. Sloan Fellow. Dr. Mathies is a member of the American Optical Society, the American Society for Photobiology, and the American Association for the Advancement of Science. His awards have included the Harold Lamport Award from the New York Academy of Sciences, the American Society for Photobiology Research Award, the Frederick Conference on Capillary Electrophoresis Award, the A.D. Little Lecturer Award from the Massachusetts Institute of Technology, the Association for Laboratory Automation 2001 Research Award, Fellow of the Optical Society of America and the Ellis R. Lippincott Award. He is advising the company on Raman theory, Raman technology and biophysical measurements.

Take advantage of these resources to learn more about the advent of truly non-invasive continuous glucose monitoring.

	In Pursuit of an Ideal – A Perspective on Non-Invasive Continuous Glucose Monitoring Lisa B English, European Endocrinology, 2012 Download Article
	Requirements for Calibration in Noninvasive Glucose Monitoring by Raman Spectroscopy Jan Lipson, Ph.D. et al., Journal of Diabetes Science and Technology, 2009 Download Article